Case report demonstrates the utility of PSMA PET/CT for distinguishing radiation-induced brain necrosis from viable tumor in prostate cancer, highlighting its superiority over conventional imaging.
This is a case of a 69-year-old patient with Prostate Cancer (PCa) who underwent PSMA PET in three different evaluation scenarios: Biochemical Relapse (BCR), response assessment and differential diagnosis between Radiation-induced Brain Necrosis (RBN), and neoplastic tissue viability. PSMA PET showed superiority compared to conventional imaging exams in all scenarios and impacted on the management of the patient.
No takes yet. Share an insight, caveat, or question.
Anna Carolina Borges da Silva (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: